Future of Off-Label Promotion

Future of Off-Label Promotion Between Dr. Gottlieb being sworn in as the new FDA commissioner and several recent court cases going in favor of the drugmakers, one has to question if we’ll see a loosening of off-label promotion rules. It’s estimated that one in five prescriptions written in the U.S….Continue reading

FacebookTwitter

Pharma Rep Access in Decline

Less than 44% of physicians are accessible to pharma reps this year compared to 51% in 2014 and 65% in 2012. Nearly a decade of data has shown a steady decline in physician access according to ZS – a global consulting and research company. That’s a big pharma marketing…Continue reading

FacebookTwitter

The Simple Pharma Executive Mistake Lowering Drug Sales

Studies show that patients think meds with simple names are safer and equally effective while drug brands become more difficult to pronounce. Stop! Pharma execs, before you name any more meds, take a closer look at the studies in the Journal of Health Psychology in which…Continue reading

FacebookTwitter

Physician Assistants In the News

Physician Assistants (PAs) continue to dominate the healthcare news. One recent article describes the ability and training of a PA to use a pair of augmented reality glasses to perform life-saving surgery on a wounded soldier in a remote location. The PA trains to save lives, limbs and eyesight…Continue reading

FacebookTwitter

Specialist Visits That Involve NPs/PAs Double

According to a research letter published June 5, 2017 in JAMA Internal Medicine, growth in NP/PA participation in specialist visits occurred not only for routine or return visits, but also for new patients and complex acute visits. The authors of the study also observed almost twice the percentage…Continue reading

FacebookTwitter
1 2 3 8